Foreløbige finansielle tal for regnskabsåret 2024
06. Januar 2025 12:16 ET
|
BioPorto A/S
6. januar 2025 Meddelelse nr. 01 Foreløbige finansielle tal for regnskabsåret 2024 København, Danmark, 6. januar, 2025, (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto eller Selskabet) (CPH:BIOPOR), et...
Preliminary Financial Figures for the 2024 Fiscal Year
06. Januar 2025 12:16 ET
|
BioPorto A/S
January 6, 2025 Announcement no. 01 Preliminary Financial Figures for the 2024 Fiscal Year COPENHAGEN, DENMARK, January 6, 2025, (GLOBE NEWSWIRE) – BioPorto A/S CVR-no. 17500317 (BioPorto or...
BioPorto commences process to appoint new Chair of the Board of Directors
16. Dezember 2024 12:53 ET
|
BioPorto A/S
December 16, 2024 Announcement no. 23 BioPorto commences process to appoint new Chair of the Board of Directors COPENHAGEN, DENMARK, December 16, 2024 (GLOBE NEWSWIRE) – The Board of Directors of...
BioPorto offentliggør delårsresultater og opdatering for tredje kvartal og ni måneder af regnskabsåret 2024
14. November 2024 02:50 ET
|
BioPorto A/S
14. november 2024 Meddelelse nr. 22 BioPorto offentliggør delårsresultater og opdatering for tredje kvartal og ni måneder af regnskabsåret 2024 ...
BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024
14. November 2024 02:50 ET
|
BioPorto A/S
November 14, 2024Announcement no. 22 BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024 Revenue growth and strategic execution COPENHAGEN,...
BioPorto A/S inviterer til webcast
12. November 2024 03:57 ET
|
BioPorto A/S
12. november 2024 Pressemeddelelse BioPorto A/S inviterer til webcast KØBENHAVN, DANMARK og BOSTON, MA, USA, 12. november, 2024 (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto eller Selskabet)...
BioPorto A/S to Host Third Quarter 2024 Earnings Webcast
12. November 2024 03:57 ET
|
BioPorto A/S
November 12, 2024 News release BioPorto A/S to Host Third Quarter 2024 Earnings Webcast COPENHAGEN, DENMARK and BOSTON, MA, USA, November 12, 2024 (GLOBE NEWSWIRE) – BioPorto A/S...
BioPorto Sponsors Exhibits to Showcase Launch of ProNephro AKI in the U.S. and Ongoing Marketing of The NGAL Test to Clinicians at Major Healthcare Conferences
08. November 2024 11:03 ET
|
BioPorto A/S
8 November 2024 New Release BioPorto Sponsors Exhibits to Showcase Launch of ProNephro AKI in the U.S. and Ongoing Marketing of The NGAL Test to Clinicians at Major Healthcare...
Grant of Warrants
04. November 2024 12:44 ET
|
BioPorto A/S
4 November 2024Announcement no. 21 Grant of Warrants COPENHAGEN, DENMARK and BOSTON, MA, USA, November 4, 2024 (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the...
Første patient indrulleret - BioPorto har påbegyndt indrullering til det amerikanske studie vedrørende ProNephro AKI (NGAL)™ til voksen brug ved Massachusetts General Hospital
29. Oktober 2024 03:56 ET
|
BioPorto A/S
29. oktober 2024Selskabsmeddelelse nr. 20 Første patient indrulleret - BioPorto har påbegyndt indrullering til det amerikanske studie vedrørende ProNephro AKI (NGAL)™ til voksen brug ved...